sb 206553 has been researched along with Brain Ischemia in 1 studies
SB 206553: a high-affinity 5-HT(2C/2B) antagonist; structure given in first source
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, LA | 1 |
| Galandak, J | 1 |
| Djali, S | 1 |
1 other study available for sb 206553 and Brain Ischemia
| Article | Year |
|---|---|
Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin.
Topics: Amino Acids; Animals; Brain Ischemia; Fluorobenzenes; Hippocampus; In Vitro Techniques; Indoles; Lig | 2002 |